Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Baxalta
Baxalta
Shire shareholders approve $32 bln Baxalta merger
Marketwatch
Fri, 05/27/16 - 12:46 pm
Shire
Baxalta
M&A
As takeover talks drag on, Baxalta staff find themselves in merger limbo
Stat
Thu, 05/19/16 - 09:44 am
Baxalta
M&A
Shire
As Shire-Baxalta merger nears, lots of unanswered questions remain
Bizjournals.com
Mon, 05/9/16 - 09:52 pm
Shire
Baxalta
M&A
Baxalta posts profit of $145 million in first quarter
Yahoo/AP
Thu, 04/28/16 - 09:33 am
Baxalta
earnings
How Could Baxalta Acquisition Become a Catalyst for Shire?
Yahoo/Market Realist
Fri, 04/8/16 - 10:51 am
Baxalta
Shire
M&A
Baxalta (BXLT) Stock Up as Shire Remains Committed to Merger
TheStreet.com
Wed, 04/6/16 - 10:36 pm
Baxalta
Shire
M&A
tax inversions
Baxter to further trim stake in Baxalta ahead of $32B Shire buyout
Mass Device
Thu, 03/17/16 - 04:57 pm
Baxter
Baxalta
M&A
Shire
devices
Baxalta posts 4Q profit of $95 million, result tops expectations
Yahoo/AP
Tue, 02/16/16 - 10:07 am
Baxalta
earnings
With Baxalta in hand, Shire's not looking to buy. But sell? Maybe
Fierce Pharma
Thu, 02/11/16 - 08:59 pm
Baxalta
Shire
M&A
Vyvanse
Baxalta drops, CTI nosedives after patient deaths & adverse events prompt FDA partial hold
BioPharma Dive
Mon, 02/8/16 - 10:24 am
Baxalta
Shire
CTI BioPharma
pacritinib
JAK inhibitors
How Shire can Fuel Another Pfizer-Allergan Type Deal
Bidness, ETC
Thu, 01/21/16 - 05:43 pm
Shire
M&A
Pfizer
Allergan
Baxalta
tax inversions
Shire-Baxalta Inc Deal: Benefits Outweigh Risks
Bidness, ETC
Tue, 01/19/16 - 08:13 am
Shire
Baxalta
M&A
Biotech Investing: This Is Undoubtedly the Craziest Stat You'll Ever See
Motley Fool
Sat, 01/16/16 - 11:41 am
biotech
Dyax
Baxalta
Shire, Baxalta Merger is Now Street-Approved: Here’s Why
Bidness, ETC
Sat, 01/16/16 - 11:29 am
Shire
Baxalta
M&A
Shire CEO thinks he can beat $500M in postmerger cost savings
Fierce Pharma
Thu, 01/14/16 - 10:13 am
Shire
Pharma CEOs
Flemming Ornskov
Baxalta
M&A
Shire's Baxalta Acquisition: An Orphan Drugs Market Dream?
Forbes
Wed, 01/13/16 - 10:45 am
Shire
Baxalta
M&A
orphan drugs
Shire says internal synergy goals from Baxalta deal higher
Yahoo/Reuters
Tue, 01/12/16 - 09:16 pm
Shire
Baxalta
M&A
Why Shire-Baxalta Merger Failed To Excite Investors
Bidness, ETC
Tue, 01/12/16 - 08:26 am
Shire
Baxalta
M&A
Baxalta, Coherus say Enbrel biosimilar succeeds in study
Yahoo/Reuters
Mon, 01/11/16 - 08:36 am
Baxalta
Coherus Biosciences
biosimilars
Enbrel
rheumatoid arthritis
CHS-0214
Shire agrees to acquire Baxalta in $32 billion deal
Marketwatch
Mon, 01/11/16 - 08:32 am
Shire
Baxalta
M&A
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »